+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Peritonitis Drug"

Peritonitis - Pipeline Insight, 2021 - Product Thumbnail Image

Peritonitis - Pipeline Insight, 2021

  • Drug Pipelines
  • September 2021
  • 60 Pages
  • Global
From
Peritonitis Disease - Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Peritonitis Disease - Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • November 2020
  • 146 Pages
  • Global
From
From
Peritonitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Peritonitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 51 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Peritonitis is a serious medical condition that affects the abdominal cavity and is caused by a bacterial infection. Treatment for peritonitis typically involves antibiotics, and the drugs used to treat this condition are part of the gastrointestinal drug market. These drugs are used to reduce inflammation, fight infection, and reduce pain. Commonly prescribed drugs for peritonitis include cephalosporins, fluoroquinolones, and metronidazole. The gastrointestinal drug market is a large and diverse market, with a wide range of drugs used to treat a variety of conditions. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. The market is highly competitive, with many companies offering a variety of drugs to treat these conditions. Some of the companies in the gastrointestinal drug market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Novartis. These companies offer a variety of drugs to treat gastrointestinal conditions, including those used to treat peritonitis. Show Less Read more